141 related articles for article (PubMed ID: 14696169)
1. Stent fracture and restenosis in the drug-eluting stent era.
Sianos G; Hofma S; Ligthart JM; Saia F; Hoye A; Lemos PA; Serruys PW
Catheter Cardiovasc Interv; 2004 Jan; 61(1):111-6. PubMed ID: 14696169
[No Abstract] [Full Text] [Related]
2. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
[No Abstract] [Full Text] [Related]
3. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management?
Kim EJ; Rha SW; Wani SP; Suh SY; Choi CU; Kim JW; Park CG; Seo HS; Oh DJ
Int J Cardiol; 2007 Sep; 120(3):417-9. PubMed ID: 17084924
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
Mixon T; Fitzsimmons P
J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
[No Abstract] [Full Text] [Related]
5. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
[TBL] [Abstract][Full Text] [Related]
6. Multi-lesion culotte and crush bifurcation stenting with sirolimus-eluting stents: long-term angiographic outcome.
Daemen J; Lemos PA; Serruys PW
J Invasive Cardiol; 2003 Nov; 15(11):653-6. PubMed ID: 14608139
[No Abstract] [Full Text] [Related]
7. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
8. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
Takebayashi H; Kobayashi Y; Dangas G; Fujii K; Mintz GS; Stone GW; Moses JW; Leon MB
Catheter Cardiovasc Interv; 2003 Dec; 60(4):496-9. PubMed ID: 14624428
[TBL] [Abstract][Full Text] [Related]
9. Oral rapamycin in the treatment of diffuse proliferative in-stent restenosis in a patient with small reference vessel.
Rodriguez AE; Fernández Pereira C; Rodríguez Alemparte M
J Invasive Cardiol; 2003 Sep; 15(9):515-8. PubMed ID: 12947212
[No Abstract] [Full Text] [Related]
10. Sirolimus-eluting stents: does a great stent still need a good interventionalist?
Carrozza JP
J Am Coll Cardiol; 2004 Mar; 43(6):1116-7. PubMed ID: 15028376
[No Abstract] [Full Text] [Related]
11. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
13. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
14. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang.
Kunadian B; Vijayalakshmi K; de Belder MA
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411
[TBL] [Abstract][Full Text] [Related]
15. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
